$GLTO
Galecto, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023059367 Filed on November 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.183M $3.300M
YoY Change 15.54% 5.5%
% of Gross Profit
Research & Development $2.768M $2.551M
YoY Change -74.3% -75.69%
% of Gross Profit
Depreciation & Amortization $23.00K $211.0K
YoY Change 9.52% 3416.67%
% of Gross Profit
Operating Expenses $5.951M $8.583M
YoY Change -56.0% -36.99%
Operating Profit -$8.583M
YoY Change -36.99%
Interest Expense $132.0K $450.0K
YoY Change -124.26% -516.67%
% of Operating Profit
Other Income/Expense, Net $447.0K
YoY Change -513.89%
Pretax Income -$6.475M -$8.140M
YoY Change -53.98% -40.71%
Income Tax
% Of Pretax Income
Net Earnings -$6.475M -$8.136M
YoY Change -53.98% -40.74%
Net Earnings / Revenue
Basic Earnings Per Share -$0.30
Diluted Earnings Per Share -$0.24 -$0.30
COMMON SHARES
Basic Shares Outstanding 27.11M 27.11M
Diluted Shares Outstanding 27.10M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.15M $44.20M
YoY Change -44.95% -36.02%
Cash & Equivalents $21.47M $23.08M
Short-Term Investments $11.69M $21.10M
Other Short-Term Assets $859.0K $200.0K
YoY Change 0.23% -31.27%
Inventory
Prepaid Expenses
Receivables $1.046M $1.400M
Other Receivables $1.718M $1.200M
Total Short-Term Assets $36.77M $47.10M
YoY Change -42.45% -33.85%
LONG-TERM ASSETS
Property, Plant & Equipment $325.0K $125.0K
YoY Change -8.96% -63.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $1.128M $2.417M
YoY Change -50.5% -13.89%
Total Long-Term Assets $1.453M $2.949M
YoY Change -84.36% -72.76%
TOTAL ASSETS
Total Short-Term Assets $36.77M $47.10M
Total Long-Term Assets $1.453M $2.949M
Total Assets $38.23M $50.05M
YoY Change -47.77% -38.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.702M $4.477M
YoY Change -49.19% 134.77%
Accrued Expenses $2.904M $8.078M
YoY Change -62.56% 16.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.830M $12.60M
YoY Change -47.48% 41.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $66.00K $100.0K
YoY Change -79.88% -77.27%
Total Long-Term Liabilities $66.00K $100.0K
YoY Change -79.88% -77.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.830M $12.60M
Total Long-Term Liabilities $66.00K $100.0K
Total Liabilities $5.896M $12.67M
YoY Change -48.44% 36.23%
SHAREHOLDERS EQUITY
Retained Earnings -$256.1M -$249.6M
YoY Change 17.64% 22.53%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.33M $37.38M
YoY Change
Total Liabilities & Shareholders Equity $38.23M $50.05M
YoY Change -47.77% -38.98%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$6.475M -$8.136M
YoY Change -53.98% -40.74%
Depreciation, Depletion And Amortization $23.00K $211.0K
YoY Change 9.52% 3416.67%
Cash From Operating Activities -$11.47M -$8.460M
YoY Change 0.23% -14.09%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $9.580M $8.280M
YoY Change -33.34% -2.01%
Cash From Investing Activities $9.580M $8.280M
YoY Change -33.15% -0.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.000K 170.0K
YoY Change -106.15% -59.91%
NET CHANGE
Cash From Operating Activities -11.47M -8.460M
Cash From Investing Activities 9.580M 8.280M
Cash From Financing Activities -4.000K 170.0K
Net Change In Cash -1.894M -10.00K
YoY Change -164.27% -99.1%
FREE CASH FLOW
Cash From Operating Activities -$11.47M -$8.460M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$11.47M -$8.460M
YoY Change -0.13% -12.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001800315
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
CY2023Q3 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2022Q4 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39655
dei Entity Registrant Name
EntityRegistrantName
GALECTO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1957007
dei Entity Address Address Line1
EntityAddressAddressLine1
75 State Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02109
dei City Area Code
CityAreaCode
+45
dei Local Phone Number
LocalPhoneNumber
70 70 52 10
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
GLTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27112697
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23078000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32786000
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
21100000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
27438000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2876000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3686000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
47054000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
63910000
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
5832000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
453000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
810000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2417000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2279000
CY2023Q3 us-gaap Assets
Assets
50049000
CY2022Q4 us-gaap Assets
Assets
73188000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4477000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3350000
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8078000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7757000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12555000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11107000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
112000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
328000
CY2023Q3 us-gaap Liabilities
Liabilities
12667000
CY2022Q4 us-gaap Liabilities
Liabilities
11435000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27112697
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27112697
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25652392
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25652392
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
286946000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
279733000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-249610000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-217736000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
46000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-244000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
37382000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61753000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50049000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73188000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2551000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10494000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21002000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37436000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3304000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3128000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9504000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10246000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
2728000
us-gaap Restructuring Costs
RestructuringCosts
2728000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
8583000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
13622000
us-gaap Operating Expenses
OperatingExpenses
33234000
us-gaap Operating Expenses
OperatingExpenses
47682000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8583000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13622000
us-gaap Operating Income Loss
OperatingIncomeLoss
-33234000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47682000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
473000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
221000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1349000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
438000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-70000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-26000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-329000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
11000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-241000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
447000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-108000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1360000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
127000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8136000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13730000
us-gaap Net Income Loss
NetIncomeLoss
-31874000
us-gaap Net Income Loss
NetIncomeLoss
-47555000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.3
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27104777
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27104777
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25491786
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25491786
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26391987
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26391987
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25342153
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25342153
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
127000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-344000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
117000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1233000
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
56000
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-82000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
173000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-442000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-70000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
183000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-426000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
290000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1605000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7953000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14156000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31584000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49160000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43700000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1464000
CY2023Q3 glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
100000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
171000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
183000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8136000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
37382000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
85065000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1398000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
420000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-426000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13730000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
72727000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61753000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4337000
glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
200000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2876000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
290000
us-gaap Net Income Loss
NetIncomeLoss
-31874000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
37382000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
117223000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4222000
glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
200000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
442000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1605000
us-gaap Net Income Loss
NetIncomeLoss
-47555000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
72727000
us-gaap Profit Loss
ProfitLoss
-31874000
us-gaap Profit Loss
ProfitLoss
-47555000
us-gaap Depreciation
Depreciation
246000
us-gaap Depreciation
Depreciation
21000
us-gaap Share Based Compensation
ShareBasedCompensation
4337000
us-gaap Share Based Compensation
ShareBasedCompensation
4222000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
406000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-447000
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-70000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
355000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
305000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
40000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
36000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-812000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7802000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
141000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
785000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1127000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
376000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
445000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3919000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-378000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-342000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25437000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31484000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
25937000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
40656000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38687000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
38865000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
155000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12750000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1946000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2876000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
442000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2876000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
442000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9811000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-32988000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1239000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32786000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62563000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23078000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28336000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
449000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-249600000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-8100000
us-gaap Profit Loss
ProfitLoss
-31900000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-13700000
us-gaap Profit Loss
ProfitLoss
-47600000
CY2023Q3 us-gaap Investments And Cash
InvestmentsAndCash
44200000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
47100000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12600000
CY2022Q4 us-gaap Investments And Cash
InvestmentsAndCash
66100000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
63900000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11100000
CY2023Q3 glto Number Of Employees Reduced Due To Restructuring
NumberOfEmployeesReducedDueToRestructuring
29
CY2023Q3 glto Work Force Reduction Precentage
WorkForceReductionPrecentage
0.70
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
3400000
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
2700000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
135000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
430000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
419000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
305000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
125000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
357000
CY2023Q3 us-gaap Depreciation
Depreciation
211000
us-gaap Depreciation
Depreciation
246000
CY2022Q3 us-gaap Depreciation
Depreciation
6000
us-gaap Depreciation
Depreciation
21000
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
39953000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
49715000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
125000
us-gaap Operating Lease Cost
OperatingLeaseCost
411000
us-gaap Operating Lease Cost
OperatingLeaseCost
368000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
121000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
134000
CY2023Q3 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1433000
CY2022Q4 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1450000
CY2023Q3 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
781000
CY2022Q4 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
792000
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
109000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
805000
CY2023Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
419000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
587000
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
134000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
52000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2876000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3686000
CY2023Q3 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
200000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
500000
CY2022Q3 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
100000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
400000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
597000
us-gaap Operating Lease Payments
OperatingLeasePayments
394000
us-gaap Operating Lease Payments
OperatingLeasePayments
368000
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
449000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
449000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
147000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
291000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
51000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
489000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
25000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
464000
CY2023Q3 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
3342000
CY2022Q4 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
6145000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4035000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
352000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
476000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
349000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
539000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8078000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7757000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5778885
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.43
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1923350
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.28
glto Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
433020
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
401979
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.57
glto Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue
11445
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7300256
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6996114
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4299129
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1464000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1398000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25491786
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25491786
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26391987
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26391987
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25342153
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4337000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4222000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.900
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
glto Employees Retention Bonus Payable
EmployeesRetentionBonusPayable
1200000
glto Employees Retention Bonus Amount
EmployeesRetentionBonusAmount
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8136000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13730000
us-gaap Net Income Loss
NetIncomeLoss
-31874000
us-gaap Net Income Loss
NetIncomeLoss
-47555000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27104777
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27104777
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25342153
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.3
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.88

Files In Submission

Name View Source Status
glto-20230930_lab.xml Edgar Link unprocessable
glto-20230930_pre.xml Edgar Link unprocessable
glto-20230930_cal.xml Edgar Link unprocessable
0000950170-23-059367-index-headers.html Edgar Link pending
0000950170-23-059367-index.html Edgar Link pending
0000950170-23-059367.txt Edgar Link pending
0000950170-23-059367-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
glto-20230930.htm Edgar Link pending
glto-20230930.xsd Edgar Link pending
glto-ex10_1.htm Edgar Link pending
glto-ex10_2.htm Edgar Link pending
glto-ex31_1.htm Edgar Link pending
glto-ex31_2.htm Edgar Link pending
glto-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
glto-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
glto-20230930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending